Anavex Life Sciences
AVXL
#7563
Rank
HK$3.06 B
Marketcap
HK$34.25
Share price
-1.12%
Change (1 day)
-42.08%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : HK$89.32 Million

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are HK$89.32 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30HK$0.11 B21.21%
2023-09-30HK$98.15 M22.42%
2022-09-30HK$80.18 M-4.64%
2021-09-30HK$84.07 M48.5%
2020-09-30HK$56.61 M43.33%
2019-09-30HK$39.5 M29.9%
2018-09-30HK$30.4 M8.63%
2017-09-30HK$27.99 M13.12%
2016-09-30HK$24.74 M20%
2015-09-30HK$20.62 M-62.91%
2014-09-30HK$55.59 M150.96%
2013-09-30HK$22.15 M-1.07%
2012-09-30HK$22.39 M113.64%
2011-09-30HK$10.48 M-58.94%
2010-09-30HK$25.52 M-22.79%
2009-09-30HK$33.06 M85.13%
2008-09-30HK$17.85 M396.99%
2007-09-30HK$3.59 M1546.83%
2006-09-30HK$0.21 M4.17%
2005-09-30HK$0.2 M972.82%
2004-09-30HK$0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
HK$4.09 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$6.49 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$1.49 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$78.74 M-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA